Recent Biotech, Cannabis, Food & Drug, & Pharma Administration News

Publication Date Organization
Feb
25
2015
 The Court’s Decision in the FLANAX US Trademark Dispute Gives Bayer a Headache Mintz
Feb
24
2015
 Pharmaceutical Uses Acquisition to Make Itself More Competitive McBrayer, McGinnis, Leslie and Kirkland, PLLC
Feb
24
2015
 Early Signs of Continued Focus on Food Information, Authenticity and Traceability? Squire Patton Boggs (US) LLP
Feb
24
2015
 CMS Takes a Measured Approach to Medicare Advantage and Part D Plan Payment Rates and Policy Changes for 2016: Increased Part D Drug Costs Set the Stage for Higher Beneficiary Premiums Epstein Becker & Green, P.C.
Feb
23
2015
 FDA Issues Final Guidance Documents on Medical Device Data Systems and Medical Mobile Apps Barnes & Thornburg LLP
Feb
20
2015
 Deja Vu All Over Again: Federal GMO Labeling Legislation Re-Introduced Mintz
Feb
19
2015
 Go For De Novo: FDA’s Revised Approach to Medical Device Accessories Sheppard, Mullin, Richter & Hampton LLP
Feb
19
2015
 Life Sciences: Protecting the Crown Jewels Sills Cummis & Gross P.C.
Feb
18
2015
 M&A, Investment or Partnering Checklist for Medtech Companies Greenberg Traurig, LLP
Feb
18
2015
 FDA Issues Guidance for Mobile Medical Applications: What Will be Subject to FDA Oversight and Enforcement? Sheppard, Mullin, Richter & Hampton LLP
Feb
18
2015
 Device Manufacturer Settles False Claims Act Allegations with DOJ for $1.25 Million Mintz
Feb
18
2015
 Growing Issues In A Miniature World: Nanomaterial Registers In The EU Squire Patton Boggs (US) LLP
Feb
16
2015
 Revised Seed Law Expected to Come into Effect Soon in China Michael Best & Friedrich LLP
Feb
13
2015
 DEA Rules On Disposal of Controlled Substances - What's Up? Poyner Spruill LLP
Feb
12
2015
 Prescribing and Telemedicine: The “Physical” Exam Epstein Becker & Green, P.C.
Feb
12
2015
 Interface without Regulation – FDA Deregulates MDDS and Related Technologies Sheppard, Mullin, Richter & Hampton LLP
Feb
12
2015
 Medicare Fraud Plea in Detroit Pill Mill Case Mahany Law
Feb
12
2015
 Filthy Pharma Chronicles – GVK Bio Fake Drug Trials Mahany Law
Feb
12
2015
 Pharmaceutical Manufacturer Agrees to Pay U.S. Government $7.9 Million for Alleged Kickback Scheme Tycko & Zavareei LLP
Feb
11
2015
 FDA Will Not Enforce Regulatory Controls for Medical Device Data Systems and Two Other Health IT Devices McDermott Will & Emery
Feb
11
2015
 European Study Finds Moderate Caffeine Use Safe Morgan, Lewis & Bockius LLP
Feb
11
2015
 Biosimilars Update re: Biologics Price Competition and Innovation Act Proskauer Rose LLP
Feb
11
2015
 House To Consider Keystone, Tax Extenders; Senate To Vote On Director Of National Drug Control Policy
Feb
11
2015
 Senate Takes Shot At Vaccine-Preventable Diseases; Health Cybersecurity Examined; GAO Reports On ICD-10 Squire Patton Boggs (US) LLP
Feb
11
2015
 FTC Tastes “Sweet” Victory: The Implications of POM Wonderful for Government Practice Mintz
Feb
10
2015
 Clinical Trial Data: Shared Resource or Private Property? Faegre Drinker
Feb
10
2015
 Important Developments in FDA Regulation of Software, Including Mobile Apps Covington & Burling LLP
Feb
10
2015
 Exploring Indian Country Marijuana Godfrey & Kahn S.C.
Displaying 10501 - 10528 of 12257
Subscribe to The 10 Latest Biological, Life Sciences, and Cleantech Law Articles
 
NLR Logo
We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up for any (or all) of our 25+ Newsletters.

 

Sign Up for any (or all) of our 25+ Newsletters